09:07 AM EDT, 07/17/2024 (MT Newswires) -- Globus Medical ( GMED ) said Wednesday that it has received the US Food and Drug Administration's 510(k) clearance for its ExcelsiusFlex robotic navigation platform and the Actify 3D total knee replacement system.

The ExcelsiusFlex assists surgeons in performing knee arthroplasty procedures, while the Actify 3D system is a knee implant that combines cementless reconstruction with anatomically compatible design, the company said.

Shares of the company were up 1.8% in recent Wednesday premarket activity.

Price: 73.44, Change: +1.30, Percent Change: +1.80